<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33067459</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71.</ArticleTitle><Pagination><StartPage>5253</StartPage><MedlinePgn>5253</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5253</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-19013-3</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71)-neutralizing antibodies correlate with protection and have potential as therapeutic agents. We isolate and characterize a panel of plasmablast-derived monoclonal antibodies from an infected child whose antibody response focuses on the plateau epitope near the icosahedral 3-fold axes. Eight of a total of 19 antibodies target this epitope and three of these potently neutralize the virus. Representative neutralizing antibodies 38-1-10A and 38-3-11A both confer effective protection against lethal EV71 challenge in hSCARB2-transgenic mice. The cryo-electron microscopy structures of the EV71 virion in complex with Fab fragments of these potent and protective antibodies reveal the details of a conserved epitope formed by residues in the BC and HI loops of VP2 and the BC and HI loops of VP3 spanning the region around the 3-fold axis. Remarkably, the two antibodies interact with the epitope in quite distinct ways. These plateau-binding antibodies provide templates for promising candidate therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kuan-Ying A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0001-6891-6945</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. arthur1726@cgmh.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan. arthur1726@cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Daming</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7188-5243</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0000-0001-9754-5303</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotecha</LastName><ForeName>Abhay</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4480-5439</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Peng-Nien</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shu-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Kuo-Chien</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yhu-Chering</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tzou-Yien</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jingshan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4015-1404</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>David I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0002-3426-4210</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK. dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot, OX11 0DE, UK. dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/N00065X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V001329/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532/Z/09/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>101122/Z/13/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33067459</ArticleId><ArticleId IdType="pmc">PMC7567869</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-19013-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-19013-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nhan LNT, et al. Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak. Eur. Surveill. 2018;23:1800590. doi: 10.2807/1560-7917.ES.2018.23.46.1800590.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.46.1800590</ArticleId><ArticleId IdType="pmc">PMC6247458</ArticleId><ArticleId IdType="pubmed">30458911</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, et al. Notes from the field: enterovirus A71 neurologic disease in children&#x2014;Colorado, 2018. Morb. Mortal. Wkly Rep. 2018;67:1017&#x2013;1018. doi: 10.15585/mmwr.mm6736a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6736a5</ArticleId><ArticleId IdType="pmc">PMC6146947</ArticleId><ArticleId IdType="pubmed">30212441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002;109:e88. doi: 10.1542/peds.109.6.e88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.6.e88</ArticleId><ArticleId IdType="pubmed">12042582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wang J. EV71 vaccine, an invaluable gift for children. Clin. Translat. Immunol. 2014;3:e28. doi: 10.1038/cti.2014.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2014.24</ArticleId><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BS, Gilman MSA, McLellan JS. Structure-based vaccine antigen design. Annu. Rev. Med. 2019;70:91&#x2013;104. doi: 10.1146/annurev-med-121217-094234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-121217-094234</ArticleId><ArticleId IdType="pmc">PMC6936610</ArticleId><ArticleId IdType="pubmed">30691364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelfrene E, Mura M, Cavaleiro Sanches A, Cavaleri M. Monoclonal antibodies as anti-infective products: a promising future? Clin. Microbiol. Infect. 2019;25:60&#x2013;64. doi: 10.1016/j.cmi.2018.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2018.04.024</ArticleId><ArticleId IdType="pmc">PMC7128139</ArticleId><ArticleId IdType="pubmed">29715552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424&#x2013;429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9:e1003511. doi: 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692&#x2013;703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, et al. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414&#x2013;419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur Huang K-Y, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat. Commun. 2017;8:762. doi: 10.1038/s41467-017-00736-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00736-9</ArticleId><ArticleId IdType="pmc">PMC5624920</ArticleId><ArticleId IdType="pubmed">28970483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey JR, et al. Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. JCI Insight. 2017;2:e92872. doi: 10.1172/jci.insight.92872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92872</ArticleId><ArticleId IdType="pmc">PMC5414559</ArticleId><ArticleId IdType="pubmed">28469084</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KA, et al. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans. Nat. Microbiol. 2019;4:306&#x2013;315. doi: 10.1038/s41564-018-0303-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0303-7</ArticleId><ArticleId IdType="pubmed">30478290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofek G, et al. Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6. J. Virol. 2014;88:2426&#x2013;2441. doi: 10.1128/JVI.02837-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02837-13</ArticleId><ArticleId IdType="pmc">PMC3958054</ArticleId><ArticleId IdType="pubmed">24335316</ArticleId></ArticleIdList></Reference><Reference><Citation>Throsby M, et al. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile virus. J. Virol. 2006;80:6982&#x2013;6992. doi: 10.1128/JVI.00551-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00551-06</ArticleId><ArticleId IdType="pmc">PMC1489037</ArticleId><ArticleId IdType="pubmed">16809304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietzner B, et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc. Natl Acad. Sci. USA. 2008;105:9727&#x2013;9732. doi: 10.1073/pnas.0803644105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803644105</ArticleId><ArticleId IdType="pmc">PMC2474524</ArticleId><ArticleId IdType="pubmed">18621685</ArticleId></ArticleIdList></Reference><Reference><Citation>Teplyakov A, et al. Antibody modeling assessment II. Structures and models. Proteins. 2014;82:1563&#x2013;1582. doi: 10.1002/prot.24554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.24554</ArticleId><ArticleId IdType="pubmed">24633955</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Q, et al. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Sci. Rep. 2017;7:46402. doi: 10.1038/srep46402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46402</ArticleId><ArticleId IdType="pmc">PMC5395816</ArticleId><ArticleId IdType="pubmed">28422137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Meng T, Chow VT, Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved &#x201c;knob&#x201d; region of VP3 protein. PLoS Negl. Trop. Dis. 2014;8:e2895. doi: 10.1371/journal.pntd.0002895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, et al. Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody. PLoS Pathog. 2016;12:e1005454. doi: 10.1371/journal.ppat.1005454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005454</ArticleId><ArticleId IdType="pmc">PMC4777393</ArticleId><ArticleId IdType="pubmed">26938634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C, et al. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses. Sci. Transl. Med. 2017;9:eaam5752. doi: 10.1126/scitranslmed.aam5752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aam5752</ArticleId><ArticleId IdType="pubmed">29046433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 2018;9:4985. doi: 10.1038/s41467-018-07531-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07531-0</ArticleId><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti D, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016;351:1339&#x2013;1342. doi: 10.1126/science.aad5224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad5224</ArticleId><ArticleId IdType="pubmed">26917593</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornburg NJ, et al. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. J. Clin. Investig. 2016;126:1482&#x2013;1494. doi: 10.1172/JCI85317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85317</ArticleId><ArticleId IdType="pmc">PMC4811156</ArticleId><ArticleId IdType="pubmed">26950424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi DK, Agarwal A, Manivel V, Rao KV, Salunke DM. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity. 2006;24:429&#x2013;438. doi: 10.1016/j.immuni.2006.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.02.010</ArticleId><ArticleId IdType="pubmed">16618601</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson CA, et al. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. EMBO J. 2008;27:2592&#x2013;2602. doi: 10.1038/emboj.2008.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2008.179</ArticleId><ArticleId IdType="pmc">PMC2567409</ArticleId><ArticleId IdType="pubmed">18772881</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis JR, Briney BS, DeLuca SL, Crowe JE, Jr, Meiler J. Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput. Biol. 2013;9:e1003045. doi: 10.1371/journal.pcbi.1003045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003045</ArticleId><ArticleId IdType="pmc">PMC3636087</ArticleId><ArticleId IdType="pubmed">23637590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndifon W, Wingreen NS, Levin SA. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl Acad. Sci. USA. 2009;106:8701&#x2013;8706. doi: 10.1073/pnas.0903427106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0903427106</ArticleId><ArticleId IdType="pmc">PMC2688967</ArticleId><ArticleId IdType="pubmed">19439657</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli NT, et al. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J. Exp. Med. 2014;211:2331&#x2013;2339. doi: 10.1084/jem.20141404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20141404</ArticleId><ArticleId IdType="pmc">PMC4235641</ArticleId><ArticleId IdType="pubmed">25348152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, D. et al. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat. Struct. Mol. Biol. 10.1038/s41594-020-0480-y (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32737466</ArticleId></ArticleIdList></Reference><Reference><Citation>Page GS, et al. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 1988;62:1781&#x2013;1794. doi: 10.1128/JVI.62.5.1781-1794.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.5.1781-1794.1988</ArticleId><ArticleId IdType="pmc">PMC253228</ArticleId><ArticleId IdType="pubmed">2451757</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, et al. Neutralizing antibodies can initiate genome release from human enterovirus 71. Proc. Natl Acad. Sci. USA. 2014;111:2134&#x2013;2139. doi: 10.1073/pnas.1320624111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320624111</ArticleId><ArticleId IdType="pmc">PMC3926013</ArticleId><ArticleId IdType="pubmed">24469789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Neutralization mechanisms of two highly potent antibodies against human enterovirus 71. mBio. 2018;9:e01013&#x2013;e01018. doi: 10.1128/mBio.01013-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01013-18</ArticleId><ArticleId IdType="pmc">PMC6030555</ArticleId><ArticleId IdType="pubmed">29970466</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J, et al. KREMEN1 is a host entry receptor for a major group of enteroviruses. Cell Host Microbe. 2018;23:636&#x2013;643 e5. doi: 10.1016/j.chom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 2011;85:4937&#x2013;4946. doi: 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Ren J, Padilla-Parra S, Fry EE, Stuart DI. Lysosome sorting of &#x3b2;-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat. Commun. 2014;5:4321. doi: 10.1038/ncomms5321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5321</ArticleId><ArticleId IdType="pmc">PMC4104448</ArticleId><ArticleId IdType="pubmed">25027712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, et al. Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie virus A10. Nat. Commun. 2020;11:38. doi: 10.1038/s41467-019-13936-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13936-2</ArticleId><ArticleId IdType="pmc">PMC6946704</ArticleId><ArticleId IdType="pubmed">31911601</ArticleId></ArticleIdList></Reference><Reference><Citation>Butan C, Filman DJ, Hogle JM. Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release. J. Virol. 2014;88:1758&#x2013;1770. doi: 10.1128/JVI.01949-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01949-13</ArticleId><ArticleId IdType="pmc">PMC3911577</ArticleId><ArticleId IdType="pubmed">24257617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 2013;4:1929. doi: 10.1038/ncomms2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2889</ArticleId><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KY, et al. A potent virus-specific antibody-secreting cell response to acute enterovirus 71 infection in children. J. Infect. Dis. 2015;212:808&#x2013;817. doi: 10.1093/infdis/jiv094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv094</ArticleId><ArticleId IdType="pubmed">25712974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettleship JE, et al. A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells. Protein Expr. Purif. 2008;62:83&#x2013;89. doi: 10.1016/j.pep.2008.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2008.06.017</ArticleId><ArticleId IdType="pubmed">18662785</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter TS, et al. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J. Appl. Crystallogr. 2003;36:308&#x2013;314. doi: 10.1107/S0021889803001997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0021889803001997</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter TS, et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D. Biol. Crystallogr. 2005;61:651&#x2013;657. doi: 10.1107/S0907444905007808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444905007808</ArticleId><ArticleId IdType="pmc">PMC7159505</ArticleId><ArticleId IdType="pubmed">15930615</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 2010;43:186&#x2013;190. doi: 10.1107/S0021889809045701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0021889809045701</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagin A, Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:22&#x2013;25. doi: 10.1107/S0907444909042589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909042589</ArticleId><ArticleId IdType="pubmed">20057045</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr. 1997;53:240&#x2013;255. doi: 10.1107/S0907444996012255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444996012255</ArticleId><ArticleId IdType="pubmed">15299926</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:213&#x2013;221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:486&#x2013;501. doi: 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronarde DN. SerialEM: a program for automated tilt series acquisition on tecnai microscopes using prediction of specimen position. Microsc. Microanal. 2003;9:1182&#x2013;1183. doi: 10.1017/S1431927603445911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1431927603445911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331&#x2013;332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216&#x2013;221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivioja T, Ravantti J, Verkhovsky A, Ukkonen E, Bamford D. Local average intensity-based method for identifying spherical particles in electron micrographs. J. Struct. Biol. 2000;131:126&#x2013;134. doi: 10.1006/jsbi.2000.4279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2000.4279</ArticleId><ArticleId IdType="pubmed">11042083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegunov D, Cramer P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods. 2019;16:1146&#x2013;1152. doi: 10.1038/s41592-019-0580-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0580-y</ArticleId><ArticleId IdType="pmc">PMC6858868</ArticleId><ArticleId IdType="pubmed">31591575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018;7:e42166. doi: 10.7554/eLife.42166.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.42166</ArticleId><ArticleId IdType="pmc">PMC6250425</ArticleId><ArticleId IdType="pubmed">30412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SH, Chen S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods. 2012;9:853&#x2013;854. doi: 10.1038/nmeth.2115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2115</ArticleId><ArticleId IdType="pmc">PMC4912033</ArticleId><ArticleId IdType="pubmed">22842542</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonine P, Headd J, Terwilliger T, Adams P. New tool: phenix. real_space_refine. Comput. Crystallogr. Newsl. 2013;4:43&#x2013;44.</Citation></Reference><Reference><Citation>Krissinel E, Henrick K. Protein interfaces, surfaces and assemblies service PISA at European Bioinformatics Institute. J. Mol. Biol. 2007;372:774&#x2013;797. doi: 10.1016/j.jmb.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.022</ArticleId><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Rossmann MG. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 2007;158:182&#x2013;187. doi: 10.1016/j.jsb.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2006.10.013</ArticleId><ArticleId IdType="pmc">PMC1978246</ArticleId><ArticleId IdType="pubmed">17116403</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLano WL, Lam JW. PyMOL: a communications tool for computational models. Abstr. Pap. Am. Chem. Soc. 2005;230:U1371&#x2013;U1372.</Citation></Reference><Reference><Citation>Pettersen EF, et al. UCSF chimera&#x2014;a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605&#x2013;1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>